Browsing: Health

Dementia has officially become the leading cause of death in Australia, overtaking coronary heart disease for the first time, according to new data released by the Australian Institute of Health and Welfare (AIHW). The report highlights the growing public health

Researchers at Michigan State University have developed a temperature-responsive gel designed to help chemotherapy patients retain their hair during treatment. The gel, which functions similarly to shampoo in application, was tested in preclinical studies and significantly reduced hair loss by

The global cholera crisis is worsening in both scale and severity, the World Health Organization (WHO) confirmed in its latest epidemiological update. Between January 1 and August 17, 2025, more than 409,000 cases of cholera and acute watery diarrhea were

Ontario will begin offering respiratory syncytial virus (RSV) vaccinations to all residents aged 75 and older starting this fall, expanding its publicly funded immunization program ahead of the annual respiratory illness season. The announcement was made by Deputy Premier and

A new peer-reviewed study has found that insufficient daily water intake may significantly heighten the body’s hormonal stress response, even in the absence of thirst or subjective signs of dehydration. Conducted by researchers at Liverpool John Moores University and published

Novo Nordisk has announced a major pricing shift for its diabetes drug Ozempic, offering it directly to U.S. patients without insurance for $499 per month. The new out-of-pocket price cuts the drug’s list cost by more than 50 percent and

New clinical guidelines released today by the American Heart Association and the American College of Cardiology recommend initiating treatment for high blood pressure earlier and call for a complete halt to alcohol consumption to reduce cardiovascular and cognitive health risks.

U.S. scientists and biotech company AOA Dx have developed a new blood test that can detect early-stage ovarian cancer with high accuracy, offering a potential breakthrough in diagnosing one of the deadliest gynecologic cancers. The findings were presented at the

The U.S. Food and Drug Administration (FDA) has elevated the recall classification for 64,800 pounds of Bunge North America Inc.’s European Style Butter Blend to a Class II level, signaling a higher risk of potential health consequences. The recall, originally